Clinical Trial Update: Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease

View source ↗

Summary

This clinical trial update describes a longitudinal biomarker study cohort for Alpha-1 antitrypsin deficiency, sponsored by Columbia University, currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Snippet

Sponsor: Columbia University | Conditions: Alpha 1-Antitrypsin Deficiency, Genetic Disease | Status: ACTIVE_NOT_RECRUITING